Additionally, technological advancements in drug delivery and ongoing patient education programs are bolstering 'Long-acting' formulations as they become increasingly recognized for their convenience and effectiveness in diabetes management
They do this by supporting GLP-1, a satiety hormone released in the gut after eating that slows down digestion and helps you feel full
When prescribed and monitored by a licensed provider, they are safe and highly effective for ongoing joint health
Ozempic (semaglutide) is a valuable option for many of our patients with type 2 diabetes
Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline
True energy boost depends on body health